An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis

Yuta Koike; Yumi Fujiki; Maho Higuchi; Reika Fukuchi; Sayaka Kuwatsuka; Hiroyuki Murota

doi:10.1016/j.jdcr.2018.11.016

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis

JAAD Case Rep. 2019 Jan 25;5(2):150-152. doi: 10.1016/j.jdcr.2018.11.016. eCollection 2019 Feb.

Authors

Yuta Koike¹, Yumi Fujiki¹, Maho Higuchi¹, Reika Fukuchi¹, Sayaka Kuwatsuka¹, Hiroyuki Murota¹

Affiliation

¹ Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

No abstract available

Keywords: ESKD, end-stage kidney disease; HBV, hepatitis B virus; HD, hemodialysis; IL, interleukin; end-stage kidney disease; hemodialysis; hepatitis B virus carrier; interleukin-17 inhibitor; ixekizumab; psoriasis.

Publication types

Case Reports